Author

C. B. Moraes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. M. Marques-Neto· 1 shared B. R. Barboza· 1 shared D. F. Sales-Medina· 1 shared D. M. Santos· 1 shared E. L. Durigon· 1 shared G. Courtemanche· 1 shared G. Palmisano· 1 shared J. Borsoi· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. M. Marques-Neto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ST8Sia2 polysialyltransferase protects against infection by Trypanosoma cruzi

B. R. Barboza, J. M. da Silva, L. A. M. Trajano-Silva, V. d. M. Gomes, D. M. Santos, A. M. Marques-Neto, S. N. Mule, J. Borsoi, C. B. Moraes, M. Muhlenhoff, W. Colli, S. K. N. Marie, L. V. Pereira, M. J. M. Alves, G. Palmisano

This study shows that ST8Sia2 polysialyltransferase reduces Trypanosoma cruzi infection by modulating host polysialylation.

bioRxiv · Nov 14, 2023 · PreprintMicrobiology

Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19

D. F. Sales-Medina, L. R. P. Ferreira, L. M. D. Romera, K. R. Goncalves, R. V. C. Guido, G. Courtemanche, M. S. Buckeridge, E. L. Durigon, C. B. Moraes, L. Freitas Junior

The paper identifies four drugs that inhibit SARS-CoV-2 in vitro infection through phenotypic screening and network analysis, providing insights for clinical repurposing.

bioRxiv · Jul 9, 2020 · PreprintMicrobiology